Spondyloperipheral dysplasia: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 28: | Line 28: | ||
{{stub}} | {{stub}} | ||
<gallery> | |||
File:Autosomal_dominant_-_en.svg | |||
</gallery> | |||
Revision as of 22:00, 16 February 2025
Spondyloperipheral dysplasia is a rare genetic disorder characterized by abnormal bone development, particularly in the spine and peripheral bones. The condition is often associated with short stature, spinal abnormalities, and deformities of the hands and feet.
Symptoms
The symptoms of spondyloperipheral dysplasia can vary greatly from person to person. However, common symptoms often include:
- Short stature
- Abnormal curvature of the spine (scoliosis)
- Abnormalities in the hands and feet, such as short fingers and toes (brachydactyly)
- Joint laxity
- Flat feet (pes planus)
Causes
Spondyloperipheral dysplasia is caused by mutations in the COL2A1 gene. This gene provides instructions for making a protein that forms type II collagen, a molecule found mostly in cartilage and the clear gel that fills the eyeball (vitreous body). Mutations in the COL2A1 gene interfere with the assembly of type II collagen molecules, which prevents bones and other connective tissues from developing properly.
Diagnosis
Diagnosis of spondyloperipheral dysplasia is typically based on physical examination and the presence of characteristic signs and symptoms. Imaging studies, such as X-rays, can reveal characteristic skeletal abnormalities. Genetic testing can confirm a diagnosis.
Treatment
There is currently no cure for spondyloperipheral dysplasia. Treatment is symptomatic and supportive, and may include physical therapy, pain management, and surgical interventions to address skeletal abnormalities.


